666 participants
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-18
- Start Date:
- 2020-10-26
- Completion:
- 2025-02-26
Conditions
- Lung Cancer, Non-Small Cell
Interventions
- DRUG
- BIOLOGICAL